Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-044868
Filing Date
2025-05-16
Accepted
2025-05-16 16:01:59
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0241513-20f_nlspharma.htm   iXBRL 20-F 2589143
2 DESCRIPTION OF SECURITIES ea024151301ex2-1_nlspharma.htm EX-2.1 117142
3 AGREEMENT OF MERGER AND PLAN OF REORGANIZATION ea024151301ex4-28_nlspharma.htm EX-4.28 18859
4 LISTING OF SUBSIDIARIES ea024151301ex8-1_nlspharma.htm EX-8.1 1961
5 INSIDER TRADING POLICY ea024151301ex11b_nlspharma.htm EX-11.B 63821
6 CERTIFICATION ea024151301ex12-1_nlspharma.htm EX-12.1 11620
7 CERTIFICATION ea024151301ex12-2_nlspharma.htm EX-12.2 11715
8 CERTIFICATION ea024151301ex13-1_nlspharma.htm EX-13.1 3947
9 CERTIFICATION ea024151301ex13-2_nlspharma.htm EX-13.2 3963
10 CONSENT OF PRICEWATERHOUSECOOPERS AG ea024151301ex15-1_nlspharma.htm EX-15.1 1960
11 CONSENT OF MARCUM LLP ea024151301ex15-2_nlspharma.htm EX-15.2 2046
12 GRAPHIC image_001.jpg GRAPHIC 23049
13 GRAPHIC image_002.jpg GRAPHIC 36310
14 GRAPHIC image_003.jpg GRAPHIC 36310
15 GRAPHIC image_004.jpg GRAPHIC 19272
16 GRAPHIC image_005.jpg GRAPHIC 19152
17 GRAPHIC image_006.jpg GRAPHIC 28655
18 GRAPHIC image_007.jpg GRAPHIC 32696
19 GRAPHIC image_008.jpg GRAPHIC 34377
20 GRAPHIC image_009.jpg GRAPHIC 57810
21 GRAPHIC image_010.jpg GRAPHIC 24003
22 GRAPHIC image_011.jpg GRAPHIC 28233
23 GRAPHIC image_012.jpg GRAPHIC 22583
24 GRAPHIC image_013.jpg GRAPHIC 11268
25 GRAPHIC image_014.jpg GRAPHIC 18471
26 GRAPHIC image_015.jpg GRAPHIC 13747
27 GRAPHIC image_016.jpg GRAPHIC 18596
28 GRAPHIC image_017.jpg GRAPHIC 50851
29 GRAPHIC image_018.jpg GRAPHIC 35860
30 GRAPHIC image_019.jpg GRAPHIC 20789
31 GRAPHIC image_020.jpg GRAPHIC 16083
32 GRAPHIC image_021.jpg GRAPHIC 22106
33 GRAPHIC image_022.jpg GRAPHIC 13545
34 GRAPHIC image_023.jpg GRAPHIC 14087
35 GRAPHIC image_024.jpg GRAPHIC 17009
36 GRAPHIC image_025.jpg GRAPHIC 20495
37 GRAPHIC image_026.jpg GRAPHIC 27807
38 GRAPHIC image_027.jpg GRAPHIC 15297
39 GRAPHIC image_028.jpg GRAPHIC 18159
40 GRAPHIC image_029.jpg GRAPHIC 15729
41 GRAPHIC image_030.jpg GRAPHIC 17800
42 GRAPHIC image_031.jpg GRAPHIC 22008
43 GRAPHIC image_032.jpg GRAPHIC 22555
44 GRAPHIC image_033.jpg GRAPHIC 20178
  Complete submission text file 0001213900-25-044868.txt   10438460

Data Files

Seq Description Document Type Size
45 XBRL SCHEMA FILE nlsp-20241231.xsd EX-101.SCH 56195
46 XBRL CALCULATION FILE nlsp-20241231_cal.xml EX-101.CAL 47573
47 XBRL DEFINITION FILE nlsp-20241231_def.xml EX-101.DEF 301942
48 XBRL LABEL FILE nlsp-20241231_lab.xml EX-101.LAB 556049
49 XBRL PRESENTATION FILE nlsp-20241231_pre.xml EX-101.PRE 318860
116 EXTRACTED XBRL INSTANCE DOCUMENT ea0241513-20f_nlspharma_htm.xml XML 605350
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39957 | Film No.: 25958903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)